Navigation Links
Ranbaxy Expands By Acquiring A Generic Company In Belgium

Indian pharmaceutical company Ranbaxy Laboratories Ltd., announced on Thursday about its overseas expansion of acquiring a generics company, Ethimed NV of Belgium. //

This is the fourth acquisition announced by the company in a week. The earlier ones included the takeover of Romania's Terapia for $324 million, GlaxoSmithKline Plc's Italian generic business and the purchase of the rights and assets to Senetek Plc's auto-injector device by the US based wholly owned subsidiary of Ranbaxy.

'The acquisition (of Ethimed) follows similar strategic moves by Ranbaxy previously in the larger European markets,' the company said in a statement.

The move will allow 'Ranbaxy to anticipate local market dynamics and capitalise on the changing business landscape, in the Benelux countries'.

Belgium is the seventh largest pharmaceutical market in Europe.

Ranbaxy plans to manage operations in the Benelux territories, including Belgium, the Netherlands and Luxembourg, out of Ethimed's present location.

'Ethimed offers Ranbaxy a ready and robust distribution network to exploit new product opportunities in the future. It also provides the company, a strong base from where we can manage and expand our operations in the Benelux countries,' said Peter Burema, president of Ranbaxy for Europe, CIS, Africa and Latin America.

‘We see this acquisition as strategic to our business in Europe.'

Ethimed is an established generics company in Belgium with a significant customer network, especially among pharmacies. It has over 20 product registrations and is ranked 10th among generic companies in Belgium.

--Edited IANS
'"/>




Page: 1

Related medicine news :

1. Ranbaxy joins hand with Cipla to co-market ciprofloxacin
2. Ranbaxy gets US FDA approval for Lisinopril
3. Ranbaxy Labs Entry Into Anti-Acne Market
4. Ranbaxy trying to make inroads in herbal drugs market
5. Lamivudine Manufactured By Ranbaxy gets the nod from the US FDA
6. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
7. Ranbaxy opens Drug discovery centre in Gurgaon
8. Ranbaxy Laboratories All Set To Export Bird Flu Vaccines
9. SRL Ranbaxy offers quicker bird flu diagnostic test
10. Diagnostic Test Launched by Ranbaxy for En Masse Screening of Bird Flu
11. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients

Post Your Comments:
(Date:11/9/2009)...drugs that inhibit estrogen, , , MONDAY...at breast cancer and osteoporosis eliminated cervi... The drugs also cleared precancerous growths in th...ncer in mice with precancerous lesions. , The b...r/osteoporosis drug raloxifene were given to mice ...
(Date:11/9/2009)...equally, study finds, , , MONDAY, Nov. ...ing drug Plavix (clopidogrel) works about the same... trials has found. , "After this study, I can s...men with this very important drug," said Dr. Jeffr...s at New York University Langone Medical Center in...
(Date:11/9/2009)...g is everybody,s buzz word today and for Recruiter...ables Recruiters and Staffers create their own pri...icate and close positions. The site also enables i...etwork with recruiters. , ...rces everyone to network more than ever and by the...
(Date:11/9/2009)... could boost self-esteem, researchers say , ...children are more likely to have handwriting probl... without autism, researchers say. , The new stu... study participants had autism spectrum disorder, ...ange for perceptual reasoning on an IQ test. , ...
(Date:11/9/2009)...gained sexual function, study says, , ...were able to restore sexual function to rabbits wi... the lab and implanting it, a new study reports. ,...archers say the technique could one day be used to...e were able to show the tissue was able to integra...
Breaking Medicine News(10 mins):Health News:Breast Cancer Drugs May Fight Cervical Cancer, Too 2Health News:No Gender Gap Found for Clot-Busting Drug 2Health News:No Gender Gap Found for Clot-Busting Drug 3Health News:Launching StaffingClub.com, a New Online Networking Platform for Recruiting and Staffing Professionals 2Health News:Handwriting Skills May Lag in Kids With Autism 2Health News:Scientists Grow New Penile Tissue in the Lab 2Health News:Scientists Grow New Penile Tissue in the Lab 3
...nt headaches that they suffer from are connected t...hers. //The pediatric neurologist Kenneth Mack led...ds of the children studied who suffer from chronic...eep problems. Dr Mack said that the researc...
... earth to slip westward, according to a study by I...lished by the Bulletin of the Geological Society o...University and his team of Italian and US scientis...producing earthquakes, mountains and rifts where t...
...foot', an ape-like beast in the Johor forests of M...//This has been done on the request of the authori...Singapore Paranormal Investigators (SPI). The medi...he creatures, reportedly three meters tall are rep...
...e contact with sick birds has died of what is thou... Health authorities at Jakarta's Infectious Diseas...ried the virus. Blood and swab samples have been s... The WHO is calling for preventive measures in...
...h, the World Health Organization and UNAIDS on the...y, //is raising doubts over the numbers that are b... A report released in 2003 had put the number...0. The report also says that in the last year ther...
... introduce a Pilot scheme called 'Primary Care Cen...ting to avail health care facilities in big hospit...nts to see their physician in outpatient facility ...hich does not require long waiting hours and journ...
Other Medicine News:Health News:Headaches Among Children And Sleep Problems Are Interrelated 2
(Date:11/9/2009)...NWOOD, Ill., Nov. 9 Lan... personal and environmental radiation monitoring s...uisitions in accordance with its long-term strateg...he acquisitions of Global Physics Solutions, Inc. ...l Saxelby, President and CEO of Landauer. "These a...
(Date:11/9/2009)...DCLIFF LAKE, N.J., Nov. 9 /PRNewswire-FirstCall/ -... today announced that it has extended the expirati...eviously announced "Modified Dutch Auction" tender...cash, up to $65,000,000 aggregate principal amount... 2.875% Senior Subordinated Convertible Notes due ...
(Date:11/9/2009)...KVILLE, Md., Nov. 9 OriGene Techno...chnology in Sweden has adopted its VERIFY Tagged A...Protein Atlas program. This program is funded by t... up to explore the human proteome systematically u...uality mono-specific antibodies in a high throughp...
Breaking Medicine Technology:Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 2Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 3Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 4Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 5Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note 2Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note 3Royal Institute of Technology Adopts OriGene Over-Expression Lysates in Human Proteome Atlas Program 2Stereotaxis Showcases Interventional Value of Magnetic Navigation at TCT 2009 58241 1Stereotaxis Showcases Interventional Value of Magnetic Navigation at TCT 2009 58241 2Stereotaxis Showcases Interventional Value of Magnetic Navigation at TCT 2009 58241 3Stereotaxis Showcases Interventional Value of Magnetic Navigation at TCT 2009 58241 430th Anniversary Edition of Mandell Douglas and Bennetts Principles and Practice of Infectious Diseases is More Relevant Than Ever 58240 130th Anniversary Edition of Mandell Douglas and Bennetts Principles and Practice of Infectious Diseases is More Relevant Than Ever 58240 230th Anniversary Edition of Mandell Douglas and Bennetts Principles and Practice of Infectious Diseases is More Relevant Than Ever 58240 330th Anniversary Edition of Mandell Douglas and Bennetts Principles and Practice of Infectious Diseases is More Relevant Than Ever 58240 4Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in First Line Metastatic Colorectal Cancer 5052 1Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in First Line Metastatic Colorectal Cancer 5052 2Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in First Line Metastatic Colorectal Cancer 5052 3Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in First Line Metastatic Colorectal Cancer 5052 4Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in First Line Metastatic Colorectal Cancer 5052 5Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in First Line Metastatic Colorectal Cancer 5052 6Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in First Line Metastatic Colorectal Cancer 5052 7Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in First Line Metastatic Colorectal Cancer 5052 8Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in First Line Metastatic Colorectal Cancer 5052 9
...euticals (Nasdaq: VIAP ), a biotechnology company...reatment of cardiovascular disease,announced today... (DSMB),for its VIA-2291 Phase 2 clinical trial pr...s current Phase 2 studies. The DSMB observed a,con...ecommended VIA,continue its ongoing trials as plan...
...cess to FOSRENOL(R) and Resources fo...PHIA, April 3, 2008 Shire Pharmaceuticals, the,gl...e launch of On Track,an innovative program designe...ens among chronic kidney disease (CKD) Stage 5 pat...hosphorus in the blood). In addition,to offering t...
Other Medicine Technology:VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program 2VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program 3VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program 4Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 2Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 3Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 4Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 5Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 6Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 7Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 8
Vannas Capsulotomy scissors angled forward
Vannas Capsulotomy scissors straight
Gills-Vannas straight capsulotomy flat handle scissors
Vannas side angled capsulotomy round handle scissors
Medicine Products: